Lukito Gozali - Kalbe Farma Head Relations
| PTKFY Stock | USD 17.03 0.00 0.00% |
Executive
Lukito Gozali is Head Relations of Kalbe Farma Tbk
| Age | 44 |
| Phone | 62 21 4287 3888 |
| Web | https://www.kalbe.co.id |
Kalbe Farma Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Klaus Moosmayer | Novartis AG ADR | 56 | |
| Samit MD | Bristol Myers Squibb | 55 | |
| Catherine Owen | Bristol Myers Squibb | 54 | |
| Steffen Lang | Novartis AG ADR | 57 | |
| John Tsai | Novartis AG ADR | 54 | |
| Joseph Eiden | Bristol Myers Squibb | 75 | |
| Flavius MD | Gilead Sciences | N/A | |
| Pierre Chancel | Sanofi ADR | 67 | |
| Charles Sawyers | Novartis AG ADR | 62 | |
| Vasant Narasimhan | Novartis AG ADR | 48 | |
| FranoisXavier Roger | Sanofi ADR | 62 | |
| Rudolf Ertl | Gilead Sciences | 78 | |
| William Winters | Novartis AG ADR | 60 | |
| Johanna Mercier | Gilead Sciences | 54 | |
| Shannon Klinger | Novartis AG ADR | 49 | |
| Etienne Jousseaume | Novartis AG ADR | N/A | |
| Madeleine Roach | Sanofi ADR | 40 | |
| Vasant MD | Novartis AG ADR | 48 | |
| Jacquie CFA | Gilead Sciences | N/A | |
| Linda Higgins | Gilead Sciences | 62 | |
| Jeffrey Pott | AstraZeneca PLC ADR | N/A | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 |
Kalbe Farma Tbk Leadership Team
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lanny Soputro, G HR | ||
| Kurniawan Suhartono, Head Unit | ||
| Bapak Vidjongtius, Corporate Secretary, Independent Director, Member of Bus. Risk Committee and Member of Good Corporate Governance Committee | ||
| Sie Djohan, Management Devel | ||
| Lukito Gozali, Head Relations |
Kalbe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Kalbe Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Current Valuation | 5.89 B | |||
| Shares Outstanding | 231.28 M | |||
| Price To Earning | 32.31 X | |||
| Price To Book | 4.75 X | |||
| Price To Sales | 3.28 X | |||
| Revenue | 26.26 T | |||
| Gross Profit | 11.11 T |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| C | Citigroup | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |